Please use this identifier to cite or link to this item:
http://repository.li.mahidol.ac.th/dspace/handle/123456789/11465
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Stuart D. Blacksell | en_US |
dc.contributor.author | Ampai Tanganuchitcharnchai | en_US |
dc.contributor.author | Richard G. Jarman | en_US |
dc.contributor.author | Robert V. Gibbons | en_US |
dc.contributor.author | Daniel H. Paris | en_US |
dc.contributor.author | Mark S. Bailey | en_US |
dc.contributor.author | Nicholas P J Day | en_US |
dc.contributor.author | Ranjan Premaratna | en_US |
dc.contributor.author | David G. Lalloo | en_US |
dc.contributor.author | H. Janaka De Silva | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | University of Oxford | en_US |
dc.contributor.other | Armed Forces Research Institute of Medical Sciences, Thailand | en_US |
dc.contributor.other | Royal Centre for Defence Medicine | en_US |
dc.contributor.other | University of Kelaniya | en_US |
dc.contributor.other | Liverpool School of Tropical Medicine | en_US |
dc.date.accessioned | 2018-05-03T08:00:14Z | - |
dc.date.available | 2018-05-03T08:00:14Z | - |
dc.date.issued | 2011-10-01 | en_US |
dc.identifier.citation | Clinical and Vaccine Immunology. Vol.18, No.10 (2011), 1773-1775 | en_US |
dc.identifier.issn | 1556679X | en_US |
dc.identifier.issn | 15566811 | en_US |
dc.identifier.other | 2-s2.0-80053447095 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80053447095&origin=inward | en_US |
dc.identifier.uri | http://repository.li.mahidol.ac.th/dspace/handle/123456789/11465 | - |
dc.description.abstract | A Sri Lankan fever cohort (n = 292 patients; 17.8% prevalence) was used to assess two standard diagnostic Chikungunya IgM tests. The immunochromatographic test (ICT) acute sample sensitivity (SN) was 1.9 to 3.9%, and specificity (SP) was 92.5 to 95.0%. The enzyme-linked immunosorbent assay (ELISA) gave an acute sample SN of 3.9% and an SP of 92.5% and a convalescent sample SN of 84% and an SP of 91%. These assays are not suitable for the acute diagnosis of Chikungunya virus infection. Copyright © 2011, American Society for Microbiology. All Rights Reserved. | en_US |
dc.rights | Mahidol University | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80053447095&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Immunology and Microbiology | en_US |
dc.subject | Medicine | en_US |
dc.title | Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infection | en_US |
dc.type | Article | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.identifier.doi | 10.1128/CVI.05288-11 | en_US |
Appears in Collections: | Scopus 2011-2015 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.